AGIO stock forecast
Our latest prediction for Agios Pharmaceuticals, Inc.'s stock price was made on the Nov. 12, 2019 when the stock price was at 33.99$.
In the short term (2weeks), AGIO's stock price should outperform the market by 2.65%. During that period the price should oscillate between -7.26% and +10.17%.
In the medium term (3months), AGIO's stock price should outperform the market by 0.32%. During that period the price should oscillate between -17.31% and +25.31%.Get email alerts
Create a solid portfolio with AGIO
About Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery and development of novel investigational medicines to treat cancer and rare genetic diseases. It focuses on diseases that are directly caused by changes in genes or chromosomes, often passed from one generation to the next. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.
At the moment the company generates 118M USD in revenues.
On its last earning announcement, the company reported a loss of -6.86$ per share.
The book value per share is 14.19$
Three months stock forecastNov. 12, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|